Anesthetic Methods and Liver Transplantation

NCT ID: NCT01936545

Last Updated: 2015-07-24

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 144 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2011-05-31
• Study Completion Date: 2015-12-31

Brief Summary

Postoperative pulmonary complications are not uncommon after liver transplantation. They can not only prolong the stay in intensive care unit and in hospital but also increase the morbidity and mortality rate. The underlying mechanisms are multifactorial, however, oxidative stress following hepatic ischemia reperfusion and the ensuing pulmonary leukocyte infiltration play an important part in the pulmonary complications. Various drugs and methods such as ischemic preconditioning have been used to lessen the production of oxidative free radicals following hepatic ischemia reperfusion. The choice of different anesthetic agents could aslo change the degree of production of oxygen species and antioxidant capacity during the operation.

Volatile and intravenous anesthetic agents can decrease oxidative injuries through different mechanisms, however, which is better in preventing the pulmonary leukocyte infiltration is still unknown.

We attempt the compare the oxidative stress and cytokine level in liver transplant recipients under desflurane or propofol anesthesia to evaluate which kind of anesthetic agent is better in this kind of surgery.

Detailed Description

The occurrence of postoperative pulmonary complications after hepatic reperfusion, such as in patients undergoing liver transplantation, is a major concern in the intensive care unit. Not only neutrophil infiltration, but also oxidative injuries, have been demonstrated after intra-operative hepatic ischemia/reperfusion (I/R) management. Previous studies have shown that reactive oxygen species (ROS) paly a major role in the ensuing damage, although I/R-induced remote organ injury is a complex and multifactorial process. Methods to reduce ROS generation, such as ischemic preconditioning, attenuate both liver and lung damage after hepatic I/R. Considering the intra-operative ROS production occurs after hepatic reperfusion , the choice of anesthetics may alter the magnitude of ROS production and the antioxidant capacity.

Volatile and non-volatile anesthetics can exert their antioxidant capacity through different mechanisms. Propofol (2,6-diisopropylphenol) has been reported to provide antioxidant capacity by scavenging free radicals. However, volatile anesthetics such as isoflurane, desflurane or sevoflurane can reduce the oxidative damage through anesthetic preconditioning. Several animal studies demonstrate that volatile anesthetics offer more protection against ischemia-reperfusion injury than intravenous anesthetics. On the contrary, intravenous anesthetics may be more protective against sepsis-induced hepatic injury than volatile anesthetics. However, there are few investigations concerning the effects of different anesthetics on remote pulmonary injuries in clinical settings.

In this study, propofol and desflurane will be used for the maintenance of anesthesia during liver transplantation. The heart function, respiratory function, liver function, kidney function, the oxidative injuries and inflammatory mediators will be compared between the two groups.

Conditions

Acute Lung Injury

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: SINGLE

Study Groups

propofol

The anesthesia was maintained with propofol during liver transplantation.

Group Type: EXPERIMENTAL

propofol during liver transplantation.

Intervention Type: DRUG

The anesthesia was maintained with propofol during liver transplantation.

Desflurane

The anesthesia was maintained with desflurane during liver transplantation.

Group Type: ACTIVE_COMPARATOR

Desflurane during liver transplantation.

Intervention Type: DRUG

The anesthesia was maintained with desflurane during liver transplantation.

Interventions

propofol during liver transplantation.

The anesthesia was maintained with propofol during liver transplantation.

Intervention Type: DRUG

Desflurane during liver transplantation.

The anesthesia was maintained with desflurane during liver transplantation.

Intervention Type: DRUG

Other Intervention Names

propofol; Desflurane

Eligibility Criteria

Inclusion Criteria

• End stage liver disease scheduled for liver transplantation in National Taiwan University Hospital

Exclusion Criteria

• Pre-existing pulmonary disease
• coma

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Taiwan University Hospital

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Kuang Cheng Chan, M.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Anesthesiology, NTUH, Taipei, Taiwan

Locations

Department of Anesthesiology, NTUH, Taipei, Taiwan

Taipei, , Taiwan

Site Status: RECRUITING

Countries

Taiwan

Central Contacts

Kuang Cheng Chan, M.D.

Role: CONTACT

jkjchan@gmail.com

886-2-23123456 ext. 62158

Facility Contacts

Kuang Cheng Chan, M.D.

Role: primary

References

Aduen JF, Stapelfeldt WH, Johnson MM, Jolles HI, Grinton SF, Divertie GD, Burger CD. Clinical relevance of time of onset, duration, and type of pulmonary edema after liver transplantation. Liver Transpl. 2003 Jul;9(7):764-71. doi: 10.1053/jlts.2003.50103.

Reference Type: BACKGROUND

PMID: 12827567 (View on PubMed)

Wu CY, Cheng YJ, Hung MH, Lin IJ, Sun WZ, Chan KC. Association between Early Acute Respiratory Distress Syndrome after Living-Donor Liver Transplantation and Perioperative Serum Biomarkers: The Role of Club Cell Protein 16. Biomed Res Int. 2019 Apr 11;2019:8958069. doi: 10.1155/2019/8958069. eCollection 2019.

Reference Type: DERIVED

PMID: 31111072 (View on PubMed)

Other Identifiers

201003116M

Identifier Type: -

Identifier Source: org_study_id